Close Menu

inflammatory bowel disease

The firm will pair up with the university's APC Microbiome Institute to develop microbiome-based therapies for patients with inflammatory bowel disease.

Three organizations are partnering to support research on epigenetic factors related to the development and treatment of the disease.

Enterome Bioscience is collaborating with AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.

NEW YORK (GenomeWeb) – Second Genome today announced a partnership with the Mayo Clinic Center for Individualized Medicine to support the development of therapeutics for multiple disease indications.

Originally published Aug. 19. Additional reporting by Molika Ashford.

NEW YORK (GenomeWeb) – 23andMe and Pfizer said today they will launch a joint research project to study genetic factors involved in the onset, progression, severity, and response to treatments for inflammatory bowel disease.

COLD SPRING HARBOR, NY (GenomeWeb) – Members of a consortium focused on finding genetic culprits underlying inflammatory bowel disease, or IBD, are demonstrating the utility of using a dense, array-based genotyping approach to fine map loci linked to the conditions in genome-wide association stud

NEW YORK (GenomeWeb) – Startup microbiome-based technology firm Enterome said today that it raised €10 million ($13.9 million) in the first tranche of a Series B financing round.

NEW YORK (GenomeWeb News) – A new study is spelling out some of the distinct gut microbiome features found in individuals diagnosed with Crohn's disease who have not yet received treatment for the condition.

To assay a common risk factor for gastrointestinal ailments, Montreal-based Micropharma this week announced this week it has completed development of a new digital PCR-based test.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.